| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2.37% | 5.33% | 53.9% | 81/138 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 1.54% | 48.08% | 87.8% | 73/138 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.82% | 82.22% | -50.6% | 76/138 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 1.66% | -38.29% | -26.22% | 86/138 | 3.05% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 2.25% | -38.52% | 116.35% | 85/138 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 1.04% | -29.25% | 131.11% | 86/138 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.45% | -67.15% | -83.27% | 90/138 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.69% | 0.75% | -26.5% | 88/138 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.66% | 15.09% | 148.98% | 78/138 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.47% | -8.13% | 7.3% | 95/138 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.37% | 7.03% | -48.69% | 75/138 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 2.67% | -89.95% | -16.04% | 105/138 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 3.18% | -91.5% | 98.75% | 98/138 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 1.6% | -93.32% | 25% | 99/138 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.28% | 2% | -95.18% | 79/138 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 26.58% | 27.79% | -28.97% | 24/138 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 37.42% | 2% | 56.31% | 9/138 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 23.94% | 139.4% | 15.1% | 9/138 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 20.8% | -26.86% | 108% | 45/138 | 25.47% | 热景生物 | 57.63% | 行业排名> |
| 2020-06-30 | 10% | 2% | -64.84% | 42/138 | 15.03% | 中红医疗 | 168% | 行业排名> |
| 2019-12-31 | 28.44% | -8.82% | -8.82% | 17/138 | 14.24% | 圣湘生物 | 112.46% | 行业排名> |
| 2018-12-31 | 31.19% | 6.56% | 6.56% | 15/138 | 12.87% | 博拓生物 | 108.13% | 行业排名> |
| 2017-12-31 | 29.27% | 2% | 2% | 16/138 | 13.76% | 圣湘生物 | 29.33% | 行业排名> |

微信公众号
证券之星APP


